Guide

Efavirenz side effects become long-term for over
one in three

Abbott answers latest Kaletra criticisms

Undiagnosed HIV at 11% in London TB cases:
Indians seriously affected

How good are new CD4 cells on HAART?

Resistance to ddI and d4T may be underestimated

Row continues over potency of Roche and Abbott Pis

HIV risk from single contact may be higher than
thought

Glasgow conference confirms swing to later
treatment